343 related articles for article (PubMed ID: 28554993)
1. A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs.
Li Q; Cai T; Huang Y; Xia X; Cole SPC; Cai Y
Nanomaterials (Basel); 2017 May; 7(6):. PubMed ID: 28554993
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
3. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Naseri N; Valizadeh H; Zakeri-Milani P
Adv Pharm Bull; 2015 Sep; 5(3):305-13. PubMed ID: 26504751
[TBL] [Abstract][Full Text] [Related]
4. Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform.
Soomherun N; Kreua-Ongarjnukool N; Niyomthai ST; Chumnanvej S
Colloids Surf B Biointerfaces; 2024 May; 237():113858. PubMed ID: 38547797
[TBL] [Abstract][Full Text] [Related]
5. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
6. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
7. Polymeric Lipid Hybrid Nanoparticles (PLNs) as Emerging Drug Delivery Platform-A Comprehensive Review of Their Properties, Preparation Methods, and Therapeutic Applications.
Sivadasan D; Sultan MH; Madkhali O; Almoshari Y; Thangavel N
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452251
[TBL] [Abstract][Full Text] [Related]
8. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
9. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
10. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
11. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
12. Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery.
Khatak S; Dureja H
Recent Pat Nanotechnol; 2015; 9(3):150-77. PubMed ID: 27009132
[TBL] [Abstract][Full Text] [Related]
13. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform.
Mandal B; Bhattacharjee H; Mittal N; Sah H; Balabathula P; Thoma LA; Wood GC
Nanomedicine; 2013 May; 9(4):474-91. PubMed ID: 23261500
[TBL] [Abstract][Full Text] [Related]
14. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
15. [Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application].
Li Y; Wu ZF; Kuang WW; Li YH; Chen BY; Yang M
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):523-530. PubMed ID: 32237509
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
17. Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability.
Pan Y; Tikekar RV; Nitin N
Int J Pharm; 2016 Sep; 511(1):322-330. PubMed ID: 27418566
[TBL] [Abstract][Full Text] [Related]
18. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.
Haider M; Abdin SM; Kamal L; Orive G
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210127
[TBL] [Abstract][Full Text] [Related]
20. Effective Delivery Routes And Strategies For Solid Lipid Nanoparticles (Sln) And Nanostructured Lipid Carriers (Nlc).
Shastri DH
Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29173154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
